Loading chat...
GA HB943
Bill
Status
Introduced
2/15/2018
Primary Sponsor
Karen Mathiak
Click for details
AI Summary
- Requires all health benefit policies delivered, issued, or renewed in Georgia on or after July 1, 2018, to cover less addictive opioids (e.g., buprenorphine), opioid addiction treatments (e.g., cognitive behavioral therapy, naloxone, naltrexone), and opioid alternative treatments (e.g., physical therapy, acupuncture, NSAIDs) deemed medically appropriate by a patient's prescriber
- Mandates that less addictive opioids, addiction treatments, and alternative treatments be offered to insureds at the same cost or less than Schedule II opioid medications
- Requires new health plan providers to cover an enrollee's ongoing less addictive opioid, addiction, or alternative treatment for at least 30 days without prior authorization when the enrollee switches plans
- Exempts insurers from covering newly required treatments not covered as of January 1, 2019, if a qualified actuary certifies that the added costs exceed 2 percent of average premiums and the Insurance Commissioner approves the certification
- Applies to all individual and group health plans in the state, including contracts for state employees and indigent care, issued by HMOs, PPOs, health care corporations, and similar entities
Legislative Description
Opioid Alternative Treatment Act; enact
Last Action
House Second Readers
2/21/2018
Full Bill Text
No bill text available